ATE382345T1 - Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe - Google Patents

Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe

Info

Publication number: ATE382345T1
Authority: AT; Austria
Prior art keywords: fluvastatin; delayed; release medicine; medicine; release
Prior art date: 1998-10-14

Application number

AT99947489T

Other languages

English (en)

Inventor

Rajen Shah

Arun Patel

Roy Sandry

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-14

Filing date

1999-10-12

Publication date

2008-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22627919&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE382345(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-12 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2008-01-15 Application granted granted Critical

2008-01-15 Publication of ATE382345T1 publication Critical patent/ATE382345T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99947489T 1998-10-14 1999-10-12 Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe ATE382345T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17249198A	1998-10-14	1998-10-14

Publications (1)

Publication Number	Publication Date
ATE382345T1 true ATE382345T1 (de)	2008-01-15

Family

ID=22627919

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99947489T ATE382345T1 (de)	1998-10-14	1999-10-12	Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe

Country Status (30)

Country	Link
EP (1)	EP1121116B1 (de)
JP (2)	JP2002527388A (de)
KR (1)	KR100517090B1 (de)
CN (1)	CN1196481C (de)
AR (2)	AR020780A1 (de)
AT (1)	ATE382345T1 (de)
AU (1)	AU765475B2 (de)
BR (1)	BR9911648A (de)
CA (1)	CA2346868C (de)
CO (1)	CO5140079A1 (de)
CY (1)	CY1107874T1 (de)
DE (1)	DE69937891T2 (de)
DK (1)	DK1121116T3 (de)
ES (1)	ES2297936T3 (de)
HK (1)	HK1040920B (de)
HU (1)	HUP0104268A3 (de)
ID (1)	ID29350A (de)
IL (2)	IL142375A0 (de)
MY (1)	MY121105A (de)
NO (1)	NO327285B1 (de)
NZ (1)	NZ511010A (de)
PE (1)	PE20001110A1 (de)
PL (1)	PL198850B1 (de)
PT (1)	PT1121116E (de)
RU (1)	RU2259826C2 (de)
SK (2)	SK286596B6 (de)
TR (1)	TR200101088T2 (de)
TW (1)	TW577738B (de)
WO (1)	WO2000021525A2 (de)
ZA (1)	ZA200103001B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6569461B1 (en)	1999-03-08	2003-05-27	Merck & Co., Inc.	Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
US6242003B1 (en) *	2000-04-13	2001-06-05	Novartis Ag	Organic compounds
WO2001093859A1 (en)	2000-06-09	2001-12-13	Lek Pharmaceuticals D.D.	Stable pharmaceutical product and formulation
ES2284709T3 (es) *	2000-09-29	2007-11-16	Solvay Pharmaceuticals B.V.	Formulacion farmaceutica de liberacion sostenida independiente de la fuerza ionica.
US20060127474A1 (en)	2001-04-11	2006-06-15	Oskar Kalb	Pharmaceutical compositions comprising fluvastatin
EP1537880A4 (de) *	2002-09-11	2009-07-01	Takeda Pharmaceutical	PRûPARAT MIT VERZ GERTER FREISETZUNG
WO2004093883A2 (en) *	2003-04-23	2004-11-04	Ferring B.V.	Sachet for a pharmaceutical composition
US8987322B2 (en)	2003-11-04	2015-03-24	Circ Pharma Research And Development Limited	Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
DE102004062475A1 (de) *	2004-12-24	2006-07-06	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
EP1940391A4 (de) *	2005-08-05	2010-01-20	Orbus Pharma Inc	Stabilisierte pharmazeutische zusammensetzungen mit verlängerter freisetzung mit einem hmg-coa-reduktase-hemmer
CN101426478A (zh) *	2006-02-24	2009-05-06	特瓦制药工业有限公司	氟伐他汀钠药物组合物
RU2356532C2 (ru) *	2007-06-01	2009-05-27	Открытое Акционерное Общество "Отечественные Лекарства"	Фармацевтическая композиция проксодолола с контролируемым высвобождением
CN102805739B (zh) *	2012-04-10	2013-08-14	宋芸	氟伐他汀钠缓释包衣滴丸及其制备方法
AU2014205356A1 (en) *	2013-01-09	2015-07-30	Edgemont Pharmaceuticals Llc	Controlled release formulations of lorazepam
CN106344535B (zh) *	2016-08-29	2019-09-20	济南康和医药科技有限公司	一种氟伐他汀钠微孔渗透泵控释片及其制备方法
SG11202005016SA (en)	2017-12-05	2020-06-29	Sunovion Pharmaceuticals Inc	Nonracemic mixtures and uses thereof
MX2020005517A (es)	2017-12-05	2020-11-09	Sunovion Pharmaceuticals Inc	Formas cristalinas y metodos de produccion de las mismas.
JP7499259B2 (ja)	2018-09-25	2024-06-13	ポンスデレオンヘルスデジグネイテッドアクティビティカンパニー	αケトグルタル酸カルシウムを製造するためのプロセス
CA3142355A1 (en)	2019-06-04	2020-12-10	Sunovion Pharmaceuticals Inc.	Modified release formulations and uses thereof
JP2022537685A (ja) *	2019-06-10	2022-08-29	ポンスデレオンヘルスデジクネイテッドアクティビティカンパニー	アルファ－ケトグルタル酸塩の持続放出組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4915954A (en) *	1987-09-03	1990-04-10	Alza Corporation	Dosage form for delivering a drug at two different rates
CA2045428A1 (en) *	1990-06-26	1991-12-27	Alfred W. Alberts	Method for enhancing the lowering of plasma cholesterol levels
GB9523752D0 (en) *	1995-11-21	1996-01-24	Pfizer Ltd	Pharmaceutical formulations
JP3276962B2 (ja) *	1995-12-22	2002-04-22	興和株式会社	安定な医薬組成物
SE9603667D0 (sv) *	1996-10-08	1996-10-08	Astra Ab	Pharmaceutical compositions

1999
- 1999-10-05 CO CO99062951A patent/CO5140079A1/es unknown
- 1999-10-12 BR BR9911648-0A patent/BR9911648A/pt not_active Application Discontinuation
- 1999-10-12 AT AT99947489T patent/ATE382345T1/de active
- 1999-10-12 DK DK99947489T patent/DK1121116T3/da active
- 1999-10-12 SK SK5054-2008A patent/SK286596B6/sk not_active IP Right Cessation
- 1999-10-12 HU HU0104268A patent/HUP0104268A3/hu not_active Application Discontinuation
- 1999-10-12 EP EP99947489A patent/EP1121116B1/de not_active Revoked
- 1999-10-12 ES ES99947489T patent/ES2297936T3/es not_active Expired - Lifetime
- 1999-10-12 AR ARP990105146A patent/AR020780A1/es not_active Application Discontinuation
- 1999-10-12 PL PL348109A patent/PL198850B1/pl unknown
- 1999-10-12 PT PT99947489T patent/PT1121116E/pt unknown
- 1999-10-12 TR TR2001/01088T patent/TR200101088T2/xx unknown
- 1999-10-12 KR KR10-2001-7004708A patent/KR100517090B1/ko active IP Right Grant
- 1999-10-12 ID IDW20010807A patent/ID29350A/id unknown
- 1999-10-12 PE PE1999001027A patent/PE20001110A1/es not_active IP Right Cessation
- 1999-10-12 RU RU2001111882/15A patent/RU2259826C2/ru active
- 1999-10-12 SK SK509-2001A patent/SK286595B6/sk not_active IP Right Cessation
- 1999-10-12 DE DE69937891T patent/DE69937891T2/de not_active Expired - Lifetime
- 1999-10-12 NZ NZ511010A patent/NZ511010A/en not_active IP Right Cessation
- 1999-10-12 AU AU60909/99A patent/AU765475B2/en not_active Expired
- 1999-10-12 JP JP2000575501A patent/JP2002527388A/ja active Pending
- 1999-10-12 WO PCT/EP1999/007627 patent/WO2000021525A2/en active Application Filing
- 1999-10-12 CA CA002346868A patent/CA2346868C/en not_active Expired - Lifetime
- 1999-10-12 IL IL14237599A patent/IL142375A0/xx unknown
- 1999-10-12 CN CNB998120812A patent/CN1196481C/zh not_active Expired - Lifetime
- 1999-10-13 MY MYPI99004430A patent/MY121105A/en unknown
- 1999-10-14 TW TW088117692A patent/TW577738B/zh not_active IP Right Cessation
2001
- 2001-04-02 IL IL142375A patent/IL142375A/en not_active IP Right Cessation
- 2001-04-04 NO NO20011695A patent/NO327285B1/no not_active IP Right Cessation
- 2001-04-11 ZA ZA200103001A patent/ZA200103001B/en unknown
2002
- 2002-04-10 HK HK02102698.9A patent/HK1040920B/zh not_active IP Right Cessation
2006
- 2006-08-14 JP JP2006221194A patent/JP4938383B2/ja not_active Expired - Fee Related
2008
- 2008-02-04 CY CY20081100134T patent/CY1107874T1/el unknown
- 2008-11-11 AR ARP080104921A patent/AR069281A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1121116A2 (de)	2001-08-08
SK5092001A3 (en)	2001-09-11
PL348109A1 (en)	2002-05-06
JP2006298945A (ja)	2006-11-02
WO2000021525A3 (en)	2000-08-10
PT1121116E (pt)	2008-03-12
DK1121116T3 (da)	2008-05-13
SK286596B6 (sk)	2009-01-07
BR9911648A (pt)	2001-03-20
AU6090999A (en)	2000-05-01
EP1121116B1 (de)	2008-01-02
IL142375A0 (en)	2002-03-10
ID29350A (id)	2001-08-23
RU2259826C2 (ru)	2005-09-10
AU765475B2 (en)	2003-09-18
HUP0104268A2 (hu)	2002-04-29
CN1196481C (zh)	2005-04-13
NO327285B1 (no)	2009-06-02
DE69937891T2 (de)	2008-12-11
HUP0104268A3 (en)	2002-06-28
ES2297936T3 (es)	2008-05-01
HK1040920A1 (en)	2002-06-28
CY1107874T1 (el)	2013-06-19
AR069281A2 (es)	2010-01-13
SK286595B6 (sk)	2009-01-07
WO2000021525A2 (en)	2000-04-20
DE69937891D1 (de)	2008-02-14
CN1328454A (zh)	2001-12-26
IL142375A (en)	2012-01-31
NZ511010A (en)	2003-10-31
ZA200103001B (en)	2002-07-11
JP4938383B2 (ja)	2012-05-23
NO20011695L (no)	2001-05-30
NO20011695D0 (no)	2001-04-04
TR200101088T2 (tr)	2001-10-22
KR100517090B1 (ko)	2005-09-27
MY121105A (en)	2005-12-30
PL198850B1 (pl)	2008-07-31
JP2002527388A (ja)	2002-08-27
TW577738B (en)	2004-03-01
CA2346868A1 (en)	2000-04-20
KR20010080156A (ko)	2001-08-22
CA2346868C (en)	2008-09-09
HK1040920B (zh)	2005-07-29
AR020780A1 (es)	2002-05-29
PE20001110A1 (es)	2000-11-01
CO5140079A1 (es)	2002-03-22

Legal Events

Date

Code

Title

Description

2008-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1121116

Country of ref document: EP

Publication	Publication Date	Title
ATE382345T1 (de)	2008-01-15	Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe
DE59814019D1 (de)	2007-07-12	2-benzoyl-cyclohexan-1,3-dione
TR199801781A3 (tr)	1999-07-21	Sapkali tarak.
NL1010255A1 (nl)	1999-04-08	Bollenplanter.
ES1040856Y (es)	1999-10-01	Envase.
ES1036909Y (es)	1998-05-01	Pupitre infantil.
DE59807073D1 (de)	2003-03-06	Substituierte 2-benzoyl-cyclohexan-1,3-dione
FI972885A0 (fi)	1997-07-07	Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
ES1041026Y (es)	1999-10-01	Vibrador terapeutico.
ES1041208Y (es)	2000-03-01	Contenedor ligero perfeccionado.
ES1042496Y (es)	2000-02-01	"pilona sumible".
ES1037395Y (es)	1998-07-01	Tendedero antilluvia.
ES1043470Y (es)	2000-05-01	Lampara terapeutica.
ITCA970019A0 (it)	1997-06-24	Beccuccio.
ES1043918Y (es)	2000-07-16	Linterna perfeccionada.
ES1037895Y (es)	1998-11-01	Lampara perfeccionada.
ITBO990070U4 (it)	1998-12-21	Vassoio - contenitore per alimenti .
ES1036158Y (es)	1997-12-01	Biberon perfeccionado.
IT1291226B1 (it)	1998-12-30	Girello per bambini.
ITPR970022V0 (it)	1997-10-16	Profilorete asimmetrico.
UA25523A (uk)	1998-12-25	Лікувальhий препарат гірчичhик
ES1037945Y (es)	1998-11-01	Envase.
ID19473A (id)	1998-07-16	24-homo-26,27-heksafluoro-kolkalsiferol
FI971438A0 (fi)	1997-04-07	Koppling laemplig foer spaennings- eller spaenningsfri arbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
FI971391A0 (fi)	1997-04-04	Koppling laemplig foer spaenningsarbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd